Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.
Age structure
COVID-19
Mathematical modeling
Nonpharmaceutical Interventions
Resurgence
SARS-CoV-2
VOC
Vaccine
Waning
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
15 07 2022
15 07 2022
Historique:
received:
12
08
2021
accepted:
23
05
2022
entrez:
15
7
2022
pubmed:
16
7
2022
medline:
20
7
2022
Statut:
epublish
Résumé
Since December 2020, public health agencies have implemented a variety of vaccination strategies to curb the spread of SARS-CoV-2, along with pre-existing Nonpharmaceutical Interventions (NPIs). Initial strategies focused on vaccinating the elderly to prevent hospitalizations and deaths, but with vaccines becoming available to the broader population, it became important to determine the optimal strategy to enable the safe lifting of NPIs while avoiding virus resurgence. We extended the classic deterministic SIR compartmental disease-transmission model to simulate the lifting of NPIs under different vaccine rollout scenarios. Using case and vaccination data from Toronto, Canada between December 28, 2020, and May 19, 2021, we estimated transmission throughout past stages of NPI escalation/relaxation to compare the impact of lifting NPIs on different dates on cases, hospitalizations, and deaths, given varying degrees of vaccine coverages by 20-year age groups, accounting for waning immunity. We found that, once coverage among the elderly is high enough (80% with at least one dose), the main age groups to target are 20-39 and 40-59 years, wherein first-dose coverage of at least 70% by mid-June 2021 is needed to minimize the possibility of resurgence if NPIs are to be lifted in the summer. While a resurgence was observed for every scenario of NPI lifting, we also found that under an optimistic vaccination coverage (70% coverage by mid-June, along with postponing reopening from August 2021 to September 2021) can reduce case counts and severe outcomes by roughly 57% by December 31, 2021. Our results suggest that focusing the vaccination strategy on the working-age population can curb the spread of SARS-CoV-2. However, even with high vaccination coverage in adults, increasing contacts and easing protective personal behaviours is not advisable since a resurgence is expected to occur, especially with an earlier reopening.
Sections du résumé
BACKGROUND
Since December 2020, public health agencies have implemented a variety of vaccination strategies to curb the spread of SARS-CoV-2, along with pre-existing Nonpharmaceutical Interventions (NPIs). Initial strategies focused on vaccinating the elderly to prevent hospitalizations and deaths, but with vaccines becoming available to the broader population, it became important to determine the optimal strategy to enable the safe lifting of NPIs while avoiding virus resurgence.
METHODS
We extended the classic deterministic SIR compartmental disease-transmission model to simulate the lifting of NPIs under different vaccine rollout scenarios. Using case and vaccination data from Toronto, Canada between December 28, 2020, and May 19, 2021, we estimated transmission throughout past stages of NPI escalation/relaxation to compare the impact of lifting NPIs on different dates on cases, hospitalizations, and deaths, given varying degrees of vaccine coverages by 20-year age groups, accounting for waning immunity.
RESULTS
We found that, once coverage among the elderly is high enough (80% with at least one dose), the main age groups to target are 20-39 and 40-59 years, wherein first-dose coverage of at least 70% by mid-June 2021 is needed to minimize the possibility of resurgence if NPIs are to be lifted in the summer. While a resurgence was observed for every scenario of NPI lifting, we also found that under an optimistic vaccination coverage (70% coverage by mid-June, along with postponing reopening from August 2021 to September 2021) can reduce case counts and severe outcomes by roughly 57% by December 31, 2021.
CONCLUSIONS
Our results suggest that focusing the vaccination strategy on the working-age population can curb the spread of SARS-CoV-2. However, even with high vaccination coverage in adults, increasing contacts and easing protective personal behaviours is not advisable since a resurgence is expected to occur, especially with an earlier reopening.
Identifiants
pubmed: 35841012
doi: 10.1186/s12889-022-13597-9
pii: 10.1186/s12889-022-13597-9
pmc: PMC9283818
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1349Informations de copyright
© 2022. The Author(s).
Références
Vaccine. 2021 May 21;39(22):2995-3006
pubmed: 33933313
Infect Dis Model. 2021 Oct 27;6:1220-1235
pubmed: 34786526
J R Soc Interface. 2021 Jul;18(180):20210009
pubmed: 34255985
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Infect Dis Model. 2021;6:15-23
pubmed: 33200107
Math Biosci. 2002 Nov-Dec;180:29-48
pubmed: 12387915
Lancet Infect Dis. 2021 Jun;21(6):793-802
pubmed: 33743847
Sci Rep. 2020 Nov 12;10(1):19662
pubmed: 33184338
Sci Adv. 2021 Feb 3;7(6):
pubmed: 33536223
J Math Biol. 1990;28(4):365-82
pubmed: 2117040
J Clin Med. 2021 Feb 04;10(4):
pubmed: 33557344
PLoS One. 2021 Mar 4;16(3):e0247439
pubmed: 33661929
Science. 2021 Feb 26;371(6532):916-921
pubmed: 33479118
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478621
Nat Med. 2021 Jun;27(6):993-998
pubmed: 33864052
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740